Mones Abu-Asab

Dr. Mones Abu-Asab holds doctorate and masters’ degrees in phylogenetic systematics from Ohio University. After a long career at NIH, he has founded Phyloncology, LLC, in 2023, a company that develops cancer diagnosis and early detection technology.

He had served as an ultrastructural scientist at the National Eye Institute, NEI (2011-2024), which is part of the National Institutes of Health (Bethesda, Maryland, USA). Before joining NEI, he had worked at the Laboratory of Pathology of the National Cancer Institute (NCI) since 1998. Additionally, he has taught at Birzeit University (Palestinian Territories, 1993-94), worked on phylogenetic analysis at the Smithsonian Institution, vaccine analysis at Water Reed Army Institute of Research, and ultrastructural pathology at the Department of Pathology of the George Washington University (1997-98).

His record of publication is diverse and includes papers and book chapters on ultrastructural pathology, bioinformatics, tumor biology, systematics, virology, traditional medical systems, and global warming. His 2001 publication on global warming prompted the advancement by a week of the famous Cherry Blossoms Festival in Washington, DC. He is also the author of several books.

Most recently, he has been advocating the application of phylogenetic analysis to high throughput metabolomic and proteomic clinical data in biomedical research. He has been publishing on the topic since 2006. His analyses have shown that phylogenetic algorithms are a multidimensional tool that can be utilized for cancer modeling, genotype profiling and subtyping, diagnosis and early detection, as well as biomarker discovery.